These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 413180)

  • 1. [Trypanosoma cruzi: the action of specific rabbit immune serums on the growth of epimastigotes in diphasic media].
    González-cappa SM; Pesce UJ; Cantarella AI; Schmuñis GA
    Rev Inst Med Trop Sao Paulo; 1977; 19(4):221-31. PubMed ID: 413180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trypanosoma cruzi: activity of mouse immune sera on the tyrpomastigote stage].
    González Cappa SM; Katzin AM; Lajmanovich S
    Medicina (B Aires); 1979; 39(2):187-92. PubMed ID: 116105
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrastructural damage of Trypanosoma cruzi epimastigotes exposed to decomplemented immune sera.
    Fernández-Presas AM; Zavala JT; Fauser IB; Merchant MT; Guerrero LR; Willms K
    Parasitol Res; 2001 Aug; 87(8):619-25. PubMed ID: 11510997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of immune serums on Trypanosoma cruzi, with observations by electron microscopy].
    Tay J; Abiti T; Rivero A
    Rev Invest Salud Publica; 1974; 34(1-2):13-29. PubMed ID: 4605482
    [No Abstract]   [Full Text] [Related]  

  • 5. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi: isolation of cloned strains and characterization of their infectivity.
    Tanuri A; de Andrade PP; de Almeida DF
    J Parasitol; 1985 Aug; 71(4):397-402. PubMed ID: 3928860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culturing and biological cloning of Trypanosoma cruzi.
    Miles MA
    Methods Mol Biol; 1993; 21():15-28. PubMed ID: 8220712
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiproliferative effect of sera from chagasic patients on Trypanosoma cruzi epimastigotes. Involvement of xanthine oxidase.
    Hernandez SM; Kolliker-Frers RA; Sanchez MS; Razzitte G; Britos RD; Fuentes ME; Schwarcz de Tarlovsky MN
    Acta Trop; 2009 Mar; 109(3):219-25. PubMed ID: 19073131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes.
    Cavallesco R; Pereira ME
    J Immunol; 1988 Jan; 140(2):617-25. PubMed ID: 3121750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Trypanosoma cruzi metacyclic forms differentiated from epimastigotes. A comparative study between both stages.
    Katzin VJ; Añasco N; de Isola EL; González Cappa SM
    Rev Inst Med Trop Sao Paulo; 1983; 25(2):55-61. PubMed ID: 6353534
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reservoirs and wild vectors of Trypanosoma cruzi. LXI. Behavioral aspects of various samples of T. cruzi in culture media].
    Ribeiro RD; Barretto MP
    Rev Bras Biol; 1975; 35(2):301-7. PubMed ID: 814587
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural programmed cell death in T. cruzi epimastigotes maintained in axenic cultures.
    Jimenez V; Paredes R; Sosa MA; Galanti N
    J Cell Biochem; 2008 Oct; 105(3):688-98. PubMed ID: 18668509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of specific antibodies in Trypanosoma cruzi infections.
    Krettli AU; Brener Z
    J Immunol; 1976 Mar; 116(3):755-60. PubMed ID: 815433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA; McMahon-Pratt D
    J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of a mixture of epimastigotes and tripomastigotes from a culture of a Mexican isolate of Trypanosoma cruzi with mouse macrophages].
    Monteon VM; Nekrassov V; Zepeda A; Aranda A; Reyes PA
    Rev Latinoam Microbiol; 1992; 34(1):43-8. PubMed ID: 1345303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
    Imaz MS; Esteva M; Velázquez E; Ruiz AM; Segura EL; Marcipar AJ
    Rev Latinoam Microbiol; 1997; 39(1-2):33-46. PubMed ID: 10932713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice.
    Kierszenbaum F; Howard JG
    J Immunol; 1976 May; 116(5):1208-11. PubMed ID: 818311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytotoxic activity of the leukocytes of chronic Chagas' disease patients against Trypanosoma cruzi].
    Olabuenaga SE; Rimoldi MT; Cardoni RL; Riera NE; Sánchez RA; Chiale P; de Bracco MM
    Medicina (B Aires); 1983; 43(2):168-74. PubMed ID: 6420643
    [No Abstract]   [Full Text] [Related]  

  • 19. Trypanosoma cruzi-induced suppressor substance. I. cellular involvement and partial characterization.
    Cunningham DS; Kuhn RE
    J Immunol; 1980 May; 124(5):2122-9. PubMed ID: 6444968
    [No Abstract]   [Full Text] [Related]  

  • 20. Trypanosoma cruzi: infectivity and virulence of trypomastigotes incubated with leukocytes and serum from patients with Chagas' disease.
    Mosca W; Briceño L; Velasco J
    Acta Cient Venez; 1992; 43(5):290-4. PubMed ID: 1343741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.